| Issue |
Med Sci (Paris)
Volume 38, Number 2, Février 2022
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 230 - 232 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2022013 | |
| Published online | 18 February 2022 | |
Inhibition des réponses immunitaires anti-tumorales par NF-κB
Vers un ciblage thérapeutique ?
Inhibition of anti-tumor immunity by NF-κB: Toward therapeutic targeting?
1
Master de cancérologie, module d’immunologie - virologie, université Claude Bernard Lyon 1, Lyon, France
2
Centre de recherche en cancérologie de Lyon, UMR Inserm 1052, CNRS 5286, centre Léon Bérard, université Claude Bernard Lyon 1, Lyon, France
* lara.revol----bauz@etu.univ-lyon1.fr
** yenkel.grinberg-bleyer@inserm.fr
Cet article ne possède pas de résumé.
© 2022 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
